West Pharmaceutical Servs Q1 2024 Adj EPS $1.56 Beats $1.26 Estimate, Sales $695.400M Beat $670.303M Estimate
Author: Benzinga Newsdesk | April 25, 2024 06:01am
West Pharmaceutical Servs (NYSE:
WST) reported quarterly earnings of $1.56 per share which beat the analyst consensus estimate of $1.26 by 23.81 percent. This is a 21.21 percent decrease over earnings of $1.98 per share from the same period last year. The company reported quarterly sales of $695.400 million which beat the analyst consensus estimate of $670.303 million by 3.74 percent. This is a 2.96 percent decrease over sales of $716.600 million the same period last year.
Posted In: WST